Tectonic Therapeutic Inc (TECX)

Finanzdaten der Tectonic Therapeutic Inc-Aktie (TECX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	11.29%24.22	27.30	21.52	21.89	22.33
Research and Development	13.53%18.05	20.87	16.34	16.93	17.19
Costs And Expenses	5.33%1.05	1.11	-	-	-
Operating Income/Loss	11.29%-24.22	-27.30	-21.52	-21.89	-22.33
Nonoperating Income/Loss	2.43%2.01	2.06	2.54	2.86	3.32
Income/Loss From Continuing Operations Before Tax	-22.21	-	-18.97	-19.04	-19.01
Income Tax Expense/Benefit	0.08	-	0.25	-	0.98
	11.71%-22.29	-25.24	-19.23	-19.04	-19.98
Attributable To Parent	11.71%-22.29	-25.24	-19.23	-19.04	-19.98
Available To Common Stockholders, Basic	11.71%-22.29	-25.24	-19.23	-19.04	-19.98
Basic Average Shares	1.04%18.96	18.77	0.13	18.71	18.68
Diluted Average Shares	1.04%18.96	18.77	0.13	18.71	18.68
Basic Earnings Per Share	11.94%-1.18	-1.34	-1.03	-1.02	-1.07
Diluted Earnings Per Share	11.94%-1.18	-1.34	-1.03	-1.02	-1.07